Potential use of Immunodaat (Botanical extract of Elderberry -Sambucus Nigra L.) in the management of Post Covid-19 symptoms- a comparative, multi-centric, randomized, clinical study
Deshpande, S.; Mundhe, N.; Deshpande, V.; Tamoli, S.; Mahadik, S.; Pawar, V.
Show abstract
BackgroundImmunodaat, a proprietary botanical extract, contains standardized extract of Elderberry (Sambucus Nigra L.). Elderberry is used as an immunity enhancer for prevention and management of various respiratory diseases and as an anti-oxidant. ObjectivesThe present study evaluated the effect of Immunodaat, in Post Covid-19 recovery. MethodsAn open labeled, comparative, randomized, multi-centric, prospective clinical study was conducted on 74 subjects who had post COVID-19 symptoms recovery from mild-moderate COVID-19 within the last 15 days. Subjects were divided equally, with 37 subjects in trial and control groups each, where subjects in trial group were given Immunodaat capsules in a dose of 250 mg Capsules twice daily along with the standard care for COVID-19 for consecutive 30 days while subjects in control group were given only the standard care for Post Covid. Subjects were evaluated for post clinical recovery signs and symptoms (like cough, fatigue, Myalgia, Joint pain, confusion, altered mood, anxiety, insomnia etc.) and lab parameters. Subjects were evaluated for quality of life using WHO QOL BREF. ResultsContinuous 30 days administration of Immunodaat showed a significant difference in reducing physical as well as mental symptoms when compared to the control group. Also, a significant improvement in quality of life was observed on WHO QOL BREF scale with the use of Immunodaat compared to the control group. Overall quality of life, energy levels and stamina levels improved with the use of Immunodaat. Subjects showed excellent tolerability and did not have any adverse effect with the use of Immunodaat. ConclusionThe study concludes that use of Immunodaat over 30 days aided to normalize the physical and mental symptoms that occurred due to Post COVID and long COVID. Immunodaat can be considered as a safe and effective natural ingredient in the management of Post COVID-19 or long COVID condition.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.